FesariusTherapeutics
New York, New York, United States · Biotechnology, Health Care, Manufacturing
FesariusTherapeutics is a commercial-stage medical technology company reimagining dermal repair. Its flagship product, DermiSphere™, is the first hydrogel Dermal Regeneration Template on the U.S. market, cleared by the FDA for managing various wound types. The company aims to transform wound care through innovative solutions that improve patient outcomes. With a focus on advancing its technologies
Key facts
- Headquarters
- New York, New York, United States
- Employees
- 15
- Industries
- Biotechnology, Health Care, Manufacturing
- Status
- Private
- Website
- fesariustherapeutics.com
- Company page
Recent activity at FesariusTherapeutics
FesariusTherapeutics funding history
| Date | Round | Amount |
|---|---|---|
| Jun 2026 | Series A | $20.0M |
Leadership
- Hamid Forouzi, Director of Medical Affairs | Bridging Science, Strategy & Clinical Impact
- Kristin Klodzen, Area Sales Director East
- Tim Obrien, Vice President of Sales & Marketing
Verified email and direct lines for FesariusTherapeutics’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
FesariusTherapeutics in the news
- /C O R R E C T I O N - FesariusTherapeutics, Inc/ - Morningstar (Oct 13, 2026)
- FesariusTherapeutics Closes Oversubscribed $20M Series A, Led by Jefferson Life Sciences, and Backed by NY Ventures, and the American Society of Plastic Surgeons - PR Newswire (Jun 10, 2026)
- FesariusTherapeutics Announces Manufacturing Agreement for DermiSphere hDRT, the first hydrogel Dermal Regeneration Template - PR Newswire (Apr 17, 2025)
- FESARIUSTHERAPEUTICS INC ANNOUNCES FDA 510(K) CLEARANCE FOR DERMISPHERE HYDROGEL DERMAL REGENERATION TEMPLATE - PR Newswire (Jan 08, 2025)
Companies similar to FesariusTherapeutics
- Endoron Medical · Biotechnology, Health Care, Manufacturing, Medical, Medical Device
- Ontogen Medtech · Biotechnology, Health Care, Manufacturing, Medical, Medical Device
- NanoVibronix · Biotechnology, Health Care, Manufacturing, Medical, Medical Device
- Planatome · Biotechnology, Health Care, Manufacturing, Medical, Medical Device
- SpineCorporation · Biotechnology, Health Care, Manufacturing, Medical, Medical Device
About FesariusTherapeutics: questions and answers
What does FesariusTherapeutics do?
FesariusTherapeutics is a commercial-stage medical technology company reimagining dermal repair. Its flagship product, DermiSphere™, is the first hydrogel Dermal Regeneration Template on the U.S. market, cleared by the FDA for managing various wound types. The company aims to transform wound care through innovative solutions that improve patient outcomes. With a focus on advancing its technologies
Where is FesariusTherapeutics headquartered?
FesariusTherapeutics is headquartered in New York, New York, United States.
How many employees does FesariusTherapeutics have?
FesariusTherapeutics has about 15 employees.
Has FesariusTherapeutics raised funding?
Yes. Fundz has recorded 1 funding event for FesariusTherapeutics. The most recent, Series A of $20.0M, was in Jun 2026.
Who leads FesariusTherapeutics?
Tim Obrien is a Vice President of Sales & Marketing at FesariusTherapeutics.
What is the latest news on FesariusTherapeutics?
On Jun 10, 2026, FesariusTherapeutics secures $20M in an oversubscribed Series A round, led by Jefferson Life Sciences, to advance its innovative DermiSphere technology.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy